MCO Form 4: Fauber Exercises Options, Sells 415 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Robert Fauber, President and CEO and Director of Moody's Corporation (MCO), reported option exercises and a sale under a Rule 10b5-1 plan. On 09/02/2025 Mr. Fauber exercised employee stock options at strike prices of $80.81 (56 shares), $94.18 (134 shares) and $113.34 (91 shares), and sold 415 shares at $503.32 per share. The filing states the transactions were made pursuant to a 10b5-1 plan adopted July 30, 2024. Following the reported transactions the beneficial ownership figures listed in the filing show 61,483.984 shares after the sale, with intermediate totals of 61,673.984; 61,807.984; and 61,898.984 shares after the respective exercises.
Positive
- None.
Negative
- None.
Insights
TL;DR: CEO exercised multiple options and sold a small block under a 10b5-1 plan; transactions are routine option exercises and a planned sale.
The filing documents three option exercises on 09/02/2025 at strike prices of $80.81, $94.18 and $113.34 for 56, 134 and 91 shares respectively, and a contemporaneous sale of 415 shares at $503.32 per share. The exercises reference vesting schedules from 2017 and 2018 and the 10b5-1 plan adopted July 30, 2024 is cited as the basis for the sale. For investors this is a disclosure of insider liquidity activity and option realizations rather than an operational update; the amounts are small relative to typical company-wide share counts and no new compensation changes are reported.
TL;DR: Disclosure complies with Section 16 reporting; use of a documented 10b5-1 plan provides affirmative defense for the sale.
The Form 4 lists the reporting person as both President and CEO and a director and shows the transactions were executed pursuant to a Rule 10b5-1 plan adopted July 30, 2024. The filing includes signature by power of attorney and provides exercise dates, strike prices and vesting origins. This is a standard compliance filing that documents insider exercises and a planned sale; it includes the necessary option and share counts and cites vesting schedules tied to grant dates in 2017 and 2018.